Jean Jacques Noubiap

Datos Biográficos

ID7757918
NOMBREJean Jacques Noubiap
NOMBRESJean Jacques
APELLIDONoubiap
FIRMANOUBIAP J J
AFILIACIONESGroote Schuur Hospital
ORCID0000-0002-7722-9757
VERIFICADOSí
TOTAL DE OBRAS34
TOTAL DE CITAS0
TOTAL COMO AUTOR34
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2015
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021

    Open AccessMichael Brauer, Gregory A Roth et al.ARTICLEThe Lancet2024

    BACKGROUND: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 ri…

  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021

    Open AccessMohsen Naghavi, Kanyin Liane Ong et al.ARTICLEThe Lancet2024

    BACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mort…

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic

    Open AccessAustin E Schumacher, Hmwe Hmwe Kyu et al.ARTICLEThe Lancet2024

    BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 cou…

  • Global, regional, and national burden of disorders affecting the nervous system, 1990–2021

    Open AccessJaimie D Steinmetz, Katrin Seeher et al.ARTICLEThe Lancet Neurology2024

    BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…

  • Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050

    Open AccessKanyin Liane Ong, Lauryn K Stafford et al.ARTICLEThe Lancet2023

    BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…

  • Research and publication ethics knowledge and practices in the health and life sciences

    Open AccessLuchuo Engelbert Bain, Ikenna D Ebuenyi et al.ARTICLEEthics Medicine and Public Health2022

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open AccessKatherine R Paulson, Katherine Paulson et al.ARTICLEThe Lancet2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open AccessMarissa B Reitsma, Parkes J Kendrick et al.ARTICLEThe Lancet2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Hearing loss prevalence and years lived with disability, 1990–2019

    Open AccessLydia M Haile, Kaloyan Kamenov et al.ARTICLEThe Lancet2021

    BACKGROUND: Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. METHODS: We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open AccessValery L Feigin, Benjamin A Stark et al.ARTICLEThe Lancet Neurology2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…

  • Accuracy of malaria diagnostic tests performed on non-invasively collected samples

    Open AccessCelestin Danwang, Jean Jacques Noubiap et al.ARTICLEBMJ Global Health2021

  • Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019

    Open AccessHaidong Wang, Kaja Abbas et al.ARTICLEThe Lancet2020

    BACKGROUND: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected sub…

  • Five insights from the Global Burden of Disease Study 2019

    Open AccessChristopher J L Murray, Cristiana Abbafati et al.ARTICLEThe Lancet2020

  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Open AccessGregory A Roth, George A Mensah et al.ARTICLEJournal of the American College…2020

    Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…

  • Global, regional, and national burden of chronic kidney disease, 1990–2017

    Open AccessBoris Bikbov, Caroline Purcell et al.ARTICLEThe Lancet2020

    BACKGROUND: Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use…

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019

    Open AccessR Lozano, Nancy Fullman et al.ARTICLEThe Lancet2020

    BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019

    Open AccessChristopher J L Murray, Aleksandr Y Aravkin et al.ARTICLEThe Lancet2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019

    Open AccessTheo Vos, Stephen S Lim et al.ARTICLEThe Lancet2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open AccessValery L Feigin, Emma Nichols et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • The rising burden of non-communicable diseases in sub-Saharan Africa

    Open AccessJean Joël Bigna, Jean Jacques NoubiapARTICLEThe Lancet Global Health2019

    Non-communicable diseases (NCDs) represent the leading cause of death worldwide, killing 41 million people each year—equivalent to 71% of all deaths globally. Among NCDs, the four top killers that together account for more than 80% of all premature NCD deaths include cardiovascular diseases (17·9 million deaths annually), cancers (9·0 million), respiratory diseases (3·9 million), and diabetes (1·6 million).1 There has been a surge in the burden o…

  • Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories

    Open AccessTahvi D Frank, Tahvi Frank et al.ARTICLEThe Lancet HIV2019

    BACKGROUND: Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories. METHODS: We determined a modelling strategy for ea…

  • Global, regional, and national burden of stroke, 1990–2016

    Open AccessCatherine Owens Johnson, Minh Nguyen et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including strok…

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open AccessDaniel Dicker, Grant Nguyen et al.ARTICLEThe Lancet2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open AccessGregory A Roth, D Abate et al.ARTICLEThe Lancet2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Alcohol use and burden for 195 countries and territories, 1990–2016

    Open AccessMax Griswold, Max G Griswold et al.ARTICLEThe Lancet2018

    BACKGROUND: Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjus…